TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/6/21 16:35 | 6/30/21 | RGRX | Regenerx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Finkelstein J J | MD | DO | P,CEO | P.d | 15 | 0.2000 | 0 | 75 | 5 | 1,713 | D | ||||||||||||||
1/28/08 18:35 | 9/6/07 | RGN | Regenerx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Finkelstein J J | MD | DO | P,CEO | P.a | 8 | 1.57 | 0 | 5 | 0 | 1,452 | D | ||||||||||||||
9/7/07 11:52 | 9/6/07 | RGN | Regenerx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Finkelstein J J | MD | DO | P,CEO | P.d | 8 | 1.57 | 0 | 5 | 0 | 1,462 | D | ||||||||||||||
5/30/06 17:23 | 5/26/06 | RGN | Regenerx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Finkelstein J J | MD | DO | P,CEO | S.d | -350 | 2.80 | 0 | -125 | -8 | 1,457 | B |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |